Pfizer Inc.
CL ˙ SNSE ˙ US7170811035
SecurityCL:PFE / Pfizer Inc.
InstitutionEquitable Trust Co
Latest Disclosed Ownership32,738 shares
Latest Disclosed Value $ 919,283
Equitable Trust Co reports 18.80% increase in ownership of PFE / Pfizer Inc.

On April 30, 2026 - Equitable Trust Co filed a 13F-HR form disclosing ownership of 32,738 shares of Pfizer Inc. (CL:PFE) valued at $919,283 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 27,557 shares of Pfizer Inc.. This represents a change in shares of 18.80% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F Pfizer Com 717081103 32,738 5,181 18.80 919 33.97 0.0250
2026-02-02 2025-12-31 13F Pfizer Com 717081103 27,557 -1,554 -5.34 686 -7.42 0.0306
2025-11-10 2025-09-30 13F Pfizer Com 717081103 29,111 0 0.00 742 5.11 0.0341
2025-07-23 2025-06-30 13F Pfizer Com 717081103 29,111 -18,330 -38.64 706 -41.35 0.0352
2025-04-25 2025-03-31 13F Pfizer Com 717081103 47,441 -2,684 -5.35 1,202 -9.56 0.0666
2025-01-28 2024-12-31 13F Pfizer Com 717081103 50,125 -620 -1.22 1,330 -9.47 0.0742
2024-10-29 2024-09-30 13F Pfizer Com 717081103 50,745 2,242 4.62 1,469 8.18 0.0942
2024-07-31 2024-06-30 13F Pfizer Com 717081103 48,503 -2,535 -4.97 1,357 -4.17 0.0933
2024-04-24 2024-03-31 13F Pfizer Com 717081103 51,038 19,255 60.58 1,416 54.75 0.0982
2024-01-25 2023-12-31 13F Pfizer Com 717081103 31,783 -7,825 -19.76 915 -30.31 0.0688
2023-11-06 2023-09-30 13F Pfizer Com 717081103 39,608 -2,884 -6.79 1,314 -15.73 0.1086
2023-08-08 2023-06-30 13F Pfizer Com 717081103 42,492 -8,282 -16.31 1,559 -24.77 0.1192
2023-05-02 2023-03-31 13F Pfizer Com 717081103 50,774 -14,179 -21.83 2,072 -37.77 0.1631
2023-02-17 2022-12-31 13F Pfizer Com 717081103 64,953 1,876 2.97 3,328 20.58 0.2623
2022-10-31 2022-09-30 13F Pfizer Com 717081103 63,077 1,737 2.83 2,760 -14.18 0.2300
2022-07-15 2022-06-30 13F Pfizer Com 717081103 61,340 4,803 8.50 3,216 9.87 0.2396
2022-05-06 2022-03-31 13F Pfizer Com 717081103 56,537 2,179 4.01 2,927 -8.82 0.1881
2022-01-31 2021-12-31 13F Pfizer Com 717081103 54,358 5,694 11.70 3,210 53.37 0.1983
2021-10-26 2021-09-30 13F Pfizer Com 717081103 48,664 -320 -0.65 2,093 9.12 0.1336
2021-08-03 2021-06-30 13F Pfizer Com 717081103 48,984 -33,027 -40.27 1,918 -35.44 0.1230
2021-05-14 2021-03-31 13F Pfizer Com 717081103 82,011 2,182 2.73 2,971 1.12 0.2213
2021-02-12 2020-12-31 13F Pfizer Com 717081103 79,829 4,045 5.34 2,938 5.65 0.2181
2020-11-13 2020-09-30 13F Pfizer Com 717081103 75,784 -228 -0.30 2,781 11.91 0.2368
2020-08-18 2020-06-30 13F Pfizer Com 717081103 76,012 1,181 1.58 2,485 1.76 0.2285
2020-05-21 2020-03-31 13F Pfizer Com 717081103 74,831 10,467 16.26 2,442 -3.13 0.2684
2020-02-18 2019-12-31 13F Pfizer Com 717081103 64,364 -24,580 -27.64 2,521 -21.12 0.2463
2019-11-19 2019-09-30 13F Pfizer Com 717081103 88,944 -1,426 -1.58 3,196 -18.37 0.3367
2019-08-16 2019-06-30 13F Pfizer Com 717081103 90,370 228 0.25 3,915 2.27 0.4155
2019-05-15 2019-03-31 13F Pfizer Com 717081103 90,142 298 0.33 3,828 -2.40 0.4421
2019-02-22 2018-12-31 13F Pfizer Com 717081103 89,844 10,206 12.82 3,922 11.74 0.5190
2018-11-15 2018-09-30 13F Pfizer Com 717081103 79,638 398 0.50 3,510 22.09 0.4090
2018-08-14 2018-06-30 13F Pfizer Com 717081103 79,240 79,240 2,875 0.3640
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.